Markus Hambek
Impact in
- Otorhinolaryngology top 2%
- Head and Neck Cancer Studies
- Ear Surgery and Otitis Media
- Sensory Systems top 5%
- Hearing, Cochlea, Tinnitus, Genetics
Papers in
-
- Head and Neck Cancer Studies 11
- Oncology 11
- HER2/EGFR in Cancer Research 7
- Cancer Treatment and Pharmacology 3
- Cytokine Signaling Pathways and Interactions 2
- Co-authors
- Rainald Knecht (27 shared papers)Oliver F. Adunka (8 shared papers)Marc H. Unkelbach (3 shared papers)Jan Kiefer (2 shared papers)Martin G. Mack (5 shared papers)Mehran Baghi (22 shared papers)Jens Wagenblast (23 shared papers)Wolfgang Gstœttner (3 shared papers)
- Journals
- Oncology Reports (2 papers)Clinical Otolaryngology (2 papers)Journal of Cancer Research and Clinical Oncology (2 papers)Head & Neck (2 papers)Advances in oto-rhino-laryngology (1 paper)
- Partner nations
- GermanyAustriaUnited States
In The Last Decade
Markus Hambek
43 papers receiving 876 citations
Peers
Comparison fields: 5 of 86
- Otorhinolaryngology 220
- Sensory Systems 94
- Cognitive Neuroscience 215
- Oncology 185
- Speech and Hearing 28
Countries citing papers authored by Markus Hambek
This map shows the geographic impact of Markus Hambek's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Markus Hambek with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Markus Hambek more than expected).
Fields of papers citing papers by Markus Hambek
This network shows the impact of papers produced by Markus Hambek. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Markus Hambek. The network helps show where Markus Hambek may publish in the future.
Co-authors
The 25 scholars most cited alongside Markus Hambek, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 44 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2004 | 196 | |
| 2 | 2004 | 86 | |
| 3 | 2005 | 54 | |
| 4 | Tumor necrosis factor alpha sensitizes low epidermal growth factor receptor (EGFR)-expressing carcinomas for anti-EGFR therapy. | 2001 | 41 |
| 5 | 2009 | 41 | |
| 6 | 2007 | 37 | |
| 7 | 2006 | 36 | |
| 8 | 2010 | 30 | |
| 9 | The efficacy of MRI with ultrasmall superparamagnetic iron oxide particles (USPIO) in head and neck cancers. | 2005 | 28 |
| 10 | 2012 | 27 | |
| 11 | Craniofacial reconstructions with bone-anchored epithesis in head and neck cancer patients--a valid way back to self-perception and social reintegration. | 2008 | 23 |
| 12 | A phase II trial of docetaxel, cisplatin and 5-fluorouracil in patients with recurrent squamous cell carcinoma of the head and neck (SCCHN). | 2006 | 22 |
| 13 | 2009 | 22 | |
| 14 | The challenge of tumor heterogeneity--different phenotypes of cancer stem cells in a head and neck squamous cell carcinoma xenograft mouse model. | 2013 | 18 |
| 15 | 2007 | 18 | |
| 16 | 2006 | 17 | |
| 17 | STAT 3 activation in head and neck squamous cell carcinomas is controlled by the EGFR. | 2005 | 16 |
| 18 | EGFR antibody-supplemented TPE-chemotherapy. Preclinical investigations to a novel approach for head and neck cancer induction treatment. | 2004 | 14 |
| 19 | 2008 | 14 | |
| 20 | Carcinomas unresponsive to either cisplatinum or anti-EGFR therapy can be growth inhibited by combination therapy of both agents. | 2003 | 12 |
About Markus Hambek
Markus Hambek is a scholar working on Otorhinolaryngology, Oncology, Molecular Biology, Radiology, Nuclear Medicine and Imaging and Neurology, having authored 44 papers that have together received 898 indexed citations. Recurring topics across this work include Head and Neck Cancer Studies (11 papers), HER2/EGFR in Cancer Research (7 papers), Ubiquitin and proteasome pathways (5 papers), Cancer Treatment and Pharmacology (3 papers), Neuroblastoma Research and Treatments (2 papers), Microtubule and mitosis dynamics (2 papers), PI3K/AKT/mTOR signaling in cancer (2 papers) and Cytokine Signaling Pathways and Interactions (2 papers). The work is most often cited by research in Otorhinolaryngology (220 citations), Sensory Systems (94 citations), Cognitive Neuroscience (215 citations), Oncology (185 citations) and Speech and Hearing (28 citations). Markus Hambek has collaborated with scholars based in Germany, Austria and United States. Frequent co-authors include Rainald Knecht, Oliver F. Adunka, Marc H. Unkelbach, Jan Kiefer, Martin G. Mack, Mehran Baghi, Jens Wagenblast, Wolfgang Gstœttner, Wolfgang Gstöttner and Andreas Radeloff. Their work appears in journals such as Oncology Reports, Clinical Otolaryngology, Journal of Cancer Research and Clinical Oncology, Head & Neck and Advances in oto-rhino-laryngology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.